Healthcare | March 02, 2026
Zenex Animal Health makes strategic European play with VievePharm acquisition
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
The facility is expected to become operational by FY2028-29
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Zydus has in-licensed FYB206, a proposed biosimilar to immuno-oncology therapy Keytruda (pembrolizumab), exclusively from Formycon AG for the U.S. and Canadian markets
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management
Meenal brings in more than 16 years of international experience across Europe, Asia and the Middle East
Subscribe To Our Newsletter & Stay Updated
